負債 変化する 日付
Abbott USD 34.05B 20.19B 2026-03
Agilent USD 3.35B 0 2025-12
Avanos Medical USD 129.1M 4.6M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Cerus USD 84.16M 791K 2024-12
Charles River Laboratories USD 2.57B 58.23M 2025-12
Danaher USD 26.56B 8.07B 2026-06
Haemonetics USD 1.22B 5K 2025-12
Illumina USD 2.54B 9M 2026-03
IQVIA Holdings USD 15.83B 109M 2026-03
Merit Medical Systems USD 821.56M 9K 2026-03
Mettler Toledo International USD 2.23B 76.47M 2026-03
Myriad Genetics USD 59.3M 19.7M 2025-03
Neogen USD 793.3M 374K 2025-12
OraSure Technologies USD 782K 465K 2024-06
Pacific Biosciences Of California USD 892.24M 653K 2023-12
Quidel USD 2.87B 40.8M 2026-03
Revvity USD 3.4B 29.2M 2025-12
STAAR Surgical USD 38.35M 764K 2025-12
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
Waters USD 1.49B 4.92M 2025-12